About Us:

Triptodur® (triptorelin) for extended-release injectable suspension is an FDA approved medication distributed in the US by Azurity Pharmaceuticals, Inc. Azurity is a privately held, specialty pharmaceutical company that focuses on developing innovative products that meet the needs of patients with underserved conditions. For more information regarding Triptodur® (triptorelin) for extended release injectable suspension, visit or send email inquiries to

Triptodur® is manufactured by Debiopharm Research & Manufacturing SA on behalf of Arbor Pharmaceuticals, LLC, a subsidiary of Azurity Pharmaceuticals, Inc. Triptodur® is a registered trademark of Debiopharm International SA.


8 Cabot Road, Suite 2000

Woburn, MA 01801



Brief summary of the materials and/or video content:

Triptodur Administration Video: Watch a step-by-step video on how to administer Triptodur.


Click here to watch the Triptodur Administration Video:

Click here to watch the Triptodur Administration Video:

Have questions? Please contact:

Enter the MAP Spotlight Raffle